Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

NCT05503108 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

10

Enrollment

OTHER

Sponsor class

Stopped fultility

Conditions

Fasting Mimicking Diet
HER2-negative Breast Cancer
Hormone Receptor-positive Breast Cancer
Pathological Complete Response
Objective Response Rate
Neoadjuvant Chemotherapy

Interventions

OTHER: Fasting Mimicking diet program

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]